IL6 and COVID-19: It is believed that a large number of COVID-19 patients will go on to develop pulmonary fibrosis, and that these changes are mediated by a number of cytokines including TGF- ß, IL-1, IL-6, and TNF-α (Delpino & Quarleri, 2020).